Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study

BACKGROUND: The aim of the present study is to evaluate the impact of metastases-directed stereotactic body radiotherapy in two groups of oligometastatic prostate cancer (PC) patients: oligorecurrent PC and oligoprogressive castration-resistant PC (oligo-CRPC). METHODS: Inclusion criteria of the pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Triggiani, Luca, Alongi, Filippo, Buglione, Michela, Detti, Beatrice, Santoni, Riccardo, Bruni, Alessio, Maranzano, Ernesto, Lohr, Frank, D’Angelillo, Rolando, Magli, Alessandro, Bonetta, Alberto, Mazzola, Rosario, Pasinetti, Nadia, Francolini, Giulio, Ingrosso, Gianluca, Trippa, Fabio, Fersino, Sergio, Borghetti, Paolo, Ghirardelli, Paolo, Magrini, Stefano Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518848/
https://www.ncbi.nlm.nih.gov/pubmed/28449007
http://dx.doi.org/10.1038/bjc.2017.103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518848/
https://www.ncbi.nlm.nih.gov/pubmed/28449007
http://dx.doi.org/10.1038/bjc.2017.103

Ejemplares similares